Vasculight Elite

... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...

Medicine Products:

Abscess Culture ABO Group & Rh Type AAT A1-Antitrypsin

(Date:7/25/2008)...s of Marketing Exclusivity Begins -, CORONA, Cali...aceuticals, Inc. (NYSE: WPI ), a leading specialt... subsidiary has commenced commercial,shipment of i... in the 40mg,strength from its Davie, Florida manu..., Watson has 180 days of marketing exclusivity for...

(Date:7/25/2008)...ion Executive, Robert J. Reilly, Joins Aethon Team...,( http://www.aethon.com ), the leading developer ...tics, today announced that Robert J. Reilly has,jo... Financial Officer., Reilly, who was most recentl...orporation,s Specialty Pharmacy Division, brings m...

(Date:7/25/2008)...ewswire/ -- The Elekta Family of Companies will,sh...ions at the 2008,American Association of Physicist... how the joint forces of Elekta, IMPAC and CMS are...g and delivery solutions that,streamline the treat...ients, as well as enhance clinician efficiency., ...

(Date:7/25/2008)...y 25 /PRNewswire/ -- AutoGenomics, Inc. today,anno...n Form S-1 with the,Securities and Exchange Commis...ing of shares of its common stock. The number of s...are expected to be offered by,AutoGenomics, Inc., ... been,determined., J.P. Morgan Securities Inc. is...

Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2 Health News:Aethon, Inc. Names New Chief Financial Officer 2 Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2 Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3 Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2

[0] Watson Launches Omeprazole Delayed-Release Capsules, 40MG [0] Aethon, Inc. Names New Chief Financial Officer [0] Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting [0] AutoGenomics, Inc. Files Registration Statement for Initial Public Offering

...ng 20 paintings by renowned masters like M.F. Husa...ment a similar theme to be etched out at Sunday's ...Week. "There are different kinds of desire in a h... fulfilled, some only dream about it. But it's som...

...n people as young as 16 whereas the phenomenon onc... says. "Nobody can escape stress in modern day li...cts like a male hormone and causes the thinning of... Shah said. "Initially, we used to see this begin...

...Saturday in Burhanpur district of Madhya Pradesh i...Maharashtra testing positive for the deadly bird f...ation will also be paid to 323 affected poultry ow...cted," said Rajesh Rajora, commissioner of the sta...

...University are pumping for a controversial theory,...e forced// into "dark states" where they can be ea... idea appears to contravene some of the most accep...y, not long ago dismissed as impossible by much of...

Other Medicine News:Health News:India Fashion Week Reveals - 'The Story Of Desire' 2 Health News:Stress Can Cause Hair loss at 16 2 Health News:Controversial Theory Says DNA Can Be Pushed To "Dark States" 2 Health News:Controversial Theory Says DNA Can Be Pushed To "Dark States" 3

India Fashion Week Reveals - 'The Story Of Desire'Stress Can Cause Hair loss at 16 More Culling in Madhya Pradesh Due to Bird Flu Fears Controversial Theory Says DNA Can Be Pushed To "Dark States"

(Date:7/24/2008)...MOUNTAIN VIEW, Calif., July 24 /PRNewswire-FirstCa... ) announced today that it has initiated,its secon...loxapine).,AZ-004 is an inhalation product candida...ation in patients with schizophrenia or bipolar di...ture and rapid pharmacokinetic,(PK) properties res...

(Date:7/24/2008)...WASHINGTON, July 24 /PRNewswire-USNewswire/ -- Hea...o not tell the whole story. The small scale,preli...line in Human,Reproduction, is based on recollecte...taining soyfoods. "This study is confounded by man... with a great deal of,caution," warned Dr. Tammy H...

(Date:7/24/2008)...Revolutionary thermometer designed to take body te...., July 24 /-- Kidz-Med, In...c. Pink Sheets: ASFX),United States distributor o...r, is pleased to announce the results of a clinica...of the University of Milan, in,Milan, Italy, which...

(Date:7/24/2008)...SOPHIA ANTIPOLIS, France, July 24 /PRNewswire-Firs...nnounced the top-line results from the 52-week,ope...ing the completion of,the 301 phase 3 study for na...ty findings and efficacy was maintained for the on...atients, global assessment scale. In,addition, the...

Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6 Soyfoods Do Not Impact Sperm Count 2 Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2 NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2 NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3 NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4 Diagnostic Imaging New Stock Symbol OTCBB 3A DIIG 3077 1 Diagnostic Imaging New Stock Symbol OTCBB 3A DIIG 3077 2 Diabetes Growth Disorders Drive Sales of Pediatric Hormone Drugs 11166 1 Diabetes Growth Disorders Drive Sales of Pediatric Hormone Drugs 11166 2 New study suggests link between environmental toxins and early onset puberty in girls 11163 1 New study suggests link between environmental toxins and early onset puberty in girls 11163 2 Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3074 1 Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3074 2 Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3074 3 Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3074 4

[0] Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)[0] Soyfoods Do Not Impact Sperm Count [0] Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers [0] NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension

...ropean Hematology,Association (EHA) -, VIENNA, Aus...nomedics, Inc. , a biopharmaceutical company focus...ncer and other serious,diseases, today announced t...Vienna, Austria, showed positive responses in pati...h a new,radioimmunotherapy (RAIT) using epratuzuma...

...007 - Geron,Corporation (Nasdaq:GERN) today announ...g that GRNOPC1, the company,s human,embryonic stem...f,spinal cord injury, evades a direct attack by th...st Ross Okamura at the Federation of,Clinical Immu...s,could mean that patients treated with GRNOPC1 wo...

Other Medicine Technology:Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2 Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3 Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4 Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5 Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2 Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3

Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System

Products	Vasculight Elite
Company	Lumenis Inc.
Item	Vasculight Elite
Features	SR Mode for the following skin treatments using photorejuvenation improves the appearance of photo-aged (sun-damaged) skin. New CDL mode and cooled Nd:YAG head provide multitemperature contact cooling for optimal control of treatment site cooling. SR head with large spot size (10 x 45mm) is light and easy to use. IPL technology enables rapid treatments resulting in increased patient satisfaction and higher practice productivity. Unique, combined approach of IPL and Nd:YAG laser optimized for deeper and superficial vessels, plus telangiectatic matting and hemosiderin staining.
Description	The VascuLight system is ideal for the physician who wishes to offer patients non-invasive solutions for a broad base of clinical applications. The innovative cooled Nd:YAG laser head delivers superior performance in the treaent of deeper lying veins. The IPL heads are the perfect complement for vascular and pigmented lesions, including IPL Skin Treaents using Photorejuvenation, as well as high-speed hair removal.
Info	Lumenis Inc. Customer Service: 877-lumenis